[1]
Hribernik, N. et al. 2024. The Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study. Radiology and Oncology. 58, 3 (Sep. 2024), 335–347.